Free Trial
Notice: Trading of Traws Pharma halted at 09:31 AM EST due to "LULD pause".

Traws Pharma (TRAW) Short Interest Ratio & Short Volume

Traws Pharma logo
$4.48 -0.01 (-0.22%)
(As of 02:15 PM ET)

Traws Pharma Short Interest Data

Traws Pharma (TRAW) has a short interest of 7,400 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -23.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 5,880 shares to cover all short positions.

Current Short Interest
7,400 shares
Previous Short Interest
9,700 shares
Change Vs. Previous Month
-23.71%
Dollar Volume Sold Short
$37,296.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
1,830,000 shares
Float Size
3,000,000 shares
Short Percent of Float
0.25%
Today's Trading Volume
3,162 shares
Average Trading Volume
5,880 shares
Today's Volume Vs. Average
54%
Short Selling Traws Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Traws Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TRAW Short Interest Over Time

TRAW Days to Cover Over Time

TRAW Percentage of Float Shorted Over Time

Traws Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20247,400 shares $37,296.00 -23.7%0.3%0.7 $5.04
10/15/20249,700 shares $46,560.00 -24.2%0.3%1.1 $4.80
9/30/202412,800 shares $75,264.00 +652.9%0.6%1.6 $5.88
9/15/20241,700 shares $594.49 -92.7%N/A0.3 $0.35
8/31/202423,400 shares $8,669.70 +2.6%0.1%0.3 $0.37
8/15/202422,800 shares $8,208.00 +40.7%0.1%0.2 $0.36
7/31/202416,200 shares $6,416.82 -60.7%0.1%0.2 $0.40
7/15/202441,200 shares $17,711.88 No Change0.2%0.4 $0.43

TRAW Short Interest - Frequently Asked Questions

What is Traws Pharma's current short interest?

Short interest is the volume of Traws Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 7,400 shares of TRAW short. 0.25% of Traws Pharma's shares are currently sold short. Learn More on Traws Pharma's current short interest.

What is a good short interest ratio for Traws Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRAW shares currently have a short interest ratio of 1.0. Learn More on Traws Pharma's short interest ratio.

What is a good short interest percentage for Traws Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Traws Pharma's floating shares are currently sold short.

Is Traws Pharma's short interest increasing or decreasing?

Traws Pharma saw a drop in short interest in October. As of October 31st, there was short interest totaling 7,400 shares, a drop of 23.7% from the previous total of 9,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Traws Pharma's float size?

Traws Pharma currently has issued a total of 1,830,000 shares. Some of Traws Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Traws Pharma currently has a public float of 3,000,000 shares.

How does Traws Pharma's short interest compare to its competitors?

0.25% of Traws Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Traws Pharma: Lexaria Bioscience Corp. (1.72%), Hookipa Pharma Inc (0.47%), Lantern Pharma Inc. (2.06%), BioVie Inc. (35.04%), ProMIS Neurosciences, Inc. (1.16%), Janone Inc. (1.13%), Acasti Pharma Inc. (2.47%), DURECT Co. (3.35%), Ocuphire Pharma, Inc. (3.59%), KALA BIO, Inc. (1.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Traws Pharma stock?

Short selling TRAW is an investing strategy that aims to generate trading profit from Traws Pharma as its price is falling. TRAW shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Traws Pharma?

A short squeeze for Traws Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRAW, which in turn drives the price of the stock up even further.

How often is Traws Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRAW, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:TRAW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners